PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 · Breast Care · 31K citations
https://doi.org/10.1159/000453569
M
Markus Wallwiener
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
620
Papers
40.0K
Citations
51
h-index
195
i10-index
Markus Wallwiener is an academic researcher from German Society of Surgery. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Cells and Metastasis & Cancer Genomics and Diagnostics. The author has an h-index of 51, co-authored 527 publications.
ORCID: 0000-0002-4139-9340Papers by this author
worksPregnancy eHealth and mHealth: user proportions and characteristics of pregnant women using Web-based information sources—a cross-sectional study
2016 · Archives of Gynecology and Obstetrics · 152 citations
https://doi.org/10.1007/s00404-016-4093-y
Endometrial hyperplasia as a risk factor of endometrial cancer
2022 · Archives of Gynecology and Obstetrics · 141 citations
https://doi.org/10.1007/s00404-021-06380-5
The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer
2012 · Breast Cancer Research and Treatment · 110 citations
https://doi.org/10.1007/s10549-012-2382-0
Prevalence of paternal perinatal depressiveness and its link to partnership satisfaction and birth concerns
2013 · Archives of Women s Mental Health · 92 citations
https://doi.org/10.1007/s00737-013-0377-4
Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status
2021 · European Journal of Cancer · 86 citations
https://doi.org/10.1016/j.ejca.2021.06.033
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat